Knowledge hub

Featured content

Our journey to becoming IVDR compliant

157 rigorous pages, 113 articles, and 15 well-thought annexes. That is the executive summary of Devyser’s IVDR journey. Worth it? – Every day of the week! The extent of the IVDR preparation explained in a few numbers, looks straightforward. Here is how it really was.

Find out more

Filter

Publications

View all

A simple NGS method for detection of sequence variants causing alpha and beta thalassemia

One oligo-mix to detect virtually all known variants for α- and β-thalassemia.

Familial hypercholesterolemia: Genetic diagnosis and cascade testing using NGS

At present, FH is greatly underdiagnosed, and most cases are not discovered.

The role of chimerism monitoring following HSCT

Today HSCT is still the only curative treatment for patients with malignant or non-malignant hematological diseases.

Overcoming limitations in the detection of mixed chimerism

This paper highlights the importance of chimerism as a diagnostic tool for clinicians treating transplanted patients.

The latest from the Devyser blog

View all

Devyser products now available in Peru

Devyser is excited to announce a new partnership with Biotecnomica in Peru! Our products have now...

Cancer overtaking heart disease as leading cause of death

Cancer is overtaking heart disease as the leading cause of death, according to a study published...

On our way to IVDR Compliance

We are very happy to announce that TÜV SÜD has verified the update of our quality management system...

Sweden’s best biotech workplace

Devyser is extremely proud to have been recognized as one of Sweden’s best workplaces (Small...